Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 30;10(1):101.
doi: 10.1038/s41405-024-00289-2.

Intravenous sedation for adults with profound acquired brain injury undergoing dental treatment - a seven-year service evaluation

Affiliations

Intravenous sedation for adults with profound acquired brain injury undergoing dental treatment - a seven-year service evaluation

Mili Doshi et al. BDJ Open. .

Abstract

Background: Dental treatment may not be possible for patients with a profound acquired brain injury without pharmacological support. Intravenous (IV) sedation with midazolam is a widely accepted, safe, and effective mode of treatment for people with a disability, but there is limited evidence in this patient cohort.

Aims: This evaluation aimed to review the IV sedation service for patients with profound acquired brain injury within the dental department at the Royal Hospital for Neuro-disability.

Method: This study was a retrospective service evaluation of IV sedation for dental treatment over seven years. Descriptive statistics are presented.

Results: In total, 303 episodes of sedation were undertaken at the Royal Hospital of Neurodisability over seven years. Ninety-two percent were graded with an American Society of Anaesthesiologists (ASA) grade 3, and one-third had a history of stroke. 91% had treatment completed successfully. Complications occurred in 7.9% of cases, but all were minor, with no resulting patient harm (e.g. a transient drop in oxygen saturation).

Conclusion: Dentist-led IV sedation with midazolam is safe and effective for dental treatment for patients with a profound acquired brain injury in a specialised setting with experienced clinicians.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Ethical approval: Ethical approval was not required for this study based on the Health Research Authority toolkit: this is a retrospective service evaluation, the participants were not randomised, and there was no change to usual clinical practice.

Figures

Fig. 1
Fig. 1
Dose (mg) of midazolam administered.

Similar articles

References

    1. Shehabi Z, Flood C, Matthew L. Midazolam use for dental conscious sedation: how safe are we? Br Dent J. 2018;224:98–104. - PubMed
    1. Ransford NJ, Manley MCG, Lewis DA, Thompson SA, Wray LJ, Boyle CA, et al. Intranasal/intravenous sedation for the dental care of adults with severe disabilities: a multicentre prospective audit. Br Dent J. 2010;208:565–9. - PubMed
    1. Salerno C, Cirio S, Zambon G, D’Avola V, Parcianello RG, Maspero C, et al. Conscious sedation for dental treatments in subjects with intellectual disability: a systematic review and meta-analysis. Int J Environ Res Public Health. 2023;20:1779. - PMC - PubMed
    1. Gu Jwen, Yang T, Kuang Yqin, Huang Hdong, Kong B, Shu Hfeng, et al. Comparison of the safety and efficacy of propofol with midazolam for sedation of patients with severe traumatic brain injury: a meta-analysis. J Crit Care. 2014;29:287–90. - PubMed
    1. Collado V, Faulks D, Nicolas E, Hennequin M. Conscious sedation procedures using intravenous midazolam for dental care in patients with different cognitive profiles: a prospective study of effectiveness and safety. PLoS ONE. 2013;8:e71240. - PMC - PubMed

LinkOut - more resources